Drugs Made In Stock Alpha and Beta Analysis

DMAA Stock   10.27  0.01  0.1%   
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Drugs Made In. It also helps investors analyze the systematic and unsystematic risks associated with investing in Drugs Made over a specified time horizon. Remember, high Drugs Made's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Drugs Made's market risk premium analysis include:
Beta
(0.01)
Alpha
0.0193
Risk
0.1
Sharpe Ratio
0.25
Expected Return
0.0254
Please note that although Drugs Made alpha is a measure of relative return and represented here as a single number, it indicates the percentage above or below your selected benchmark (i.e., Dow Jones Industrial index.) So in this particular case, Drugs Made did 0.02  better than the index. Remember, a high alpha is always good. Beta, on the other hand, measures the volatility (or risk) of an investment. It is an indication of Drugs Made In stock's relative risk over its benchmark. Drugs Made In has a beta of 0.01  . As returns on the market increase, returns on owning Drugs Made are expected to decrease at a much lower rate. During the bear market, Drugs Made is likely to outperform the market. .
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Check out Drugs Made Backtesting, Drugs Made Valuation, Drugs Made Correlation, Drugs Made Hype Analysis, Drugs Made Volatility, Drugs Made History and analyze Drugs Made Performance.

Drugs Made Market Premiums

Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Drugs Made market risk premium is the additional return an investor will receive from holding Drugs Made long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Drugs Made. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Drugs Made's performance over market.
α0.02   β-0.0089

Drugs Made expected buy-and-hold returns

Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Drugs Made's Buy-and-hold return. Our buy-and-hold chart shows how Drugs Made performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.

Drugs Made Market Price Analysis

Market price analysis indicators help investors to evaluate how Drugs Made stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Drugs Made shares will generate the highest return on investment. By understating and applying Drugs Made stock market price indicators, traders can identify Drugs Made position entry and exit signals to maximize returns.

Drugs Made Return and Market Media

The median price of Drugs Made for the period between Sun, May 4, 2025 and Sat, Aug 2, 2025 is 10.18 with a coefficient of variation of 0.55. The daily time series for the period is distributed with a sample standard deviation of 0.06, arithmetic mean of 10.17, and mean deviation of 0.05. The Stock received substential amount of media coverage during this period.
 Price Growth (%)  
       Timeline  
1
VRTX Stock Down as Q1 Sales of New Drugs Miss Expectations - Nasdaq
05/07/2025
2
Tesla stock poised for weekly gain as Musk prepares to make full return to company amid alleged drug abuse - Yahoo Finance
05/30/2025
3
3 Generic Drug Stocks to Watch Amid Pricing Pressure Tariff Threats - Yahoo Finance
06/09/2025
4
William Blair initiates Contineum stock with outperform on MS drug potential - Investing.com
06/18/2025
5
Syndax stock rises after FDA grants Priority Review for cancer drug expansion - Investing.com India
06/24/2025
6
Summit Therapeutics stock initiated with Buy rating at UBS on cancer drug potential - Investing.com
06/30/2025
7
OKYO Pharma stock surges after positive Phase 2 results for eye pain drug - Investing.com
07/16/2025
8
What analysts say about Drugs Made In America Acquisition Corp. Equity Right stock - Exponentially increasing returns - Autocar Professional
07/24/2025
9
Replimune Faces Securities Class Action Following Stocks Collapse Amid FDAs Rejection of Melanoma Drug - Hagens Berman - TradingView
07/29/2025

About Drugs Made Beta and Alpha

For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Drugs or other stocks. Alpha measures the amount that position in Drugs Made In has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Drugs Made in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Drugs Made's short interest history, or implied volatility extrapolated from Drugs Made options trading.

Build Portfolio with Drugs Made

Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.

Build Diversified Portfolios

Align your risk with return expectations

By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
When determining whether Drugs Made In is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Drugs Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Drugs Made In Stock. Highlighted below are key reports to facilitate an investment decision about Drugs Made In Stock:
Drugs Made technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Drugs Made technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Drugs Made trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...